Oral administration with 150 mg/day quercetin for six weeks decreases systolic blood pressure (SBP) and plasma oxidized LDL (ox-LDL) concentrations [26], and in women with T2D, oral 500 mg/day quercetin significantly reduced the serum concentration of tumor necrosis factor α (TNF-α) and IL-6, as well as SBP [27]. Here, TNF is linked to type 2 diabetes mellitus.